toripalimab

E1997221 UNEXPLORED

Toripalimab is a humanized monoclonal antibody immune checkpoint inhibitor used in cancer immunotherapy to enhance T-cell–mediated anti-tumor responses.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
toripalimab canonical 1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

PD-1 isTargetOfDrug toripalimab